ETF Managers Group, LLC Collegium Pharmaceutical, Inc Transaction History

ETF Managers Group, LLC

  • $2.78 Billion
  • Q1 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 01, 2019
SELL
$14.78 - $19.68 $900,131 - $1.2 Million
-60,902 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$14.16 - $24.3 $82,807 - $142,106
5,848 Added 10.62%
60,902 $898,000
Q2 2018

Aug 14, 2018
BUY
$21.79 - $28.29 $1.2 Million - $1.56 Million
55,054 New
55,054 $1.25 Million

Others Institutions Holding COLL

# of Institutions
231
Shares Held
39.5M
Call Options Held
104K
Put Options Held
15.4K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.09B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email